Assessment of Serum CD25 Level in Systemic Sclerosis Patients with or Without Interstitial Lung Disease (ILD)
Not yet recruitingOBSERVATIONAL
Enrollment
66
Participants
Timeline
Start Date
October 1, 2024
Primary Completion Date
October 1, 2026
Study Completion Date
July 1, 2027
Conditions
Assessment of Serum Level of SCD25 in RA, SSc (with or Without ILD) and IPF and Its Correlation with Disease Activity
Interventions
DIAGNOSTIC_TEST
blood sampling
blood sample to detect sCD25 from systemic sclerosis and Healthy control.
All Listed Sponsors
lead
Assiut University
OTHER
NCT06615128 - Assessment of Serum CD25 Level in Systemic Sclerosis Patients with or Without Interstitial Lung Disease (ILD) | Biotech Hunter | Biotech Hunter